Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rui Xu
Institutions:
BridgeBio Oncology Therapeutics (United States),
Taiyuan University of Technology
Observed institutions:
BridgeBio Oncology Therapeutics (United States),
Taiyuan University of Technology
ORCID:
0000-0003-2017-6145
Observed ORCID:
0000-0003-2017-6145
OpenAlex ID:
A5132556092
Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026
·
Carlos Stahlhut
, Anna E. Maciag
, et al.
·
Cancer Discovery
·
12
A multiscale topological characterization approach for identifying vital nodes in complex networks
2026
·
Yubo Guan
, Ailian Wang
, et al.
·
Neurocomputing
·
2
Abstract 7104: BBO-11818: An orally bioavailable, highly potent and selective non-covalent pan-KRAS(ON) and (OFF) inhibitor with robust anti-tumor activity in KRAS-mutant preclinical models
2026
·
Carlos E. Stahlhut Espinosa
, Anna E. Maciag
, et al.
·
Cancer Research
·
1
Supplementary Figure S6 from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026
·
Carlos Stahlhut
, Anna E. Maciag
, et al.
Supplementary Figure S7 from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026
·
Carlos Stahlhut
, Anna E. Maciag
, et al.
Supplementary Table S2 from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026
·
Carlos Stahlhut
, Anna E. Maciag
, et al.
Supplementary Figure S5 from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026
·
Carlos Stahlhut
, Anna E. Maciag
, et al.
Supplementary Figure S1 from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026
·
Carlos Stahlhut
, Anna E. Maciag
, et al.
Supplementary Figure S2 from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026
·
Carlos Stahlhut
, Anna E. Maciag
, et al.
Supplementary Figure S3 from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026
·
Carlos Stahlhut
, Anna E. Maciag
, et al.
Data from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026
·
Carlos Stahlhut
, Anna E. Maciag
, et al.
Supplementary Figure S8 from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026
·
Carlos Stahlhut
, Anna E. Maciag
, et al.
Supplementary Table S1 from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026
·
Carlos Stahlhut
, Anna E. Maciag
, et al.
Supplementary Figure S4 from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026
·
Carlos Stahlhut
, Anna E. Maciag
, et al.
Supplementary Table S3 from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026
·
Carlos Stahlhut
, Anna E. Maciag
, et al.
Suppl. Materials and Methods 1 from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026
·
Carlos Stahlhut
, Anna E. Maciag
, et al.
Show more works
View as search
Works count:
16
Citation count:
15
H-index:
2
I10-index:
1
Year
Topic
Type